Literature DB >> 19656450

Structural and kinetic characterization of mutant human uroporphyrinogen decarboxylases.

C A Warby1, J D Phillips, H A Bergonia, F G Whitby, C P Hill, J P Kushner.   

Abstract

Porphyria cutanea tarda (PCT) is caused by inhibition of uroporphyrinogen decarboxylase (URO-D) activity in hepatocytes. Subnormal URO-D activity results in accumulation and urinary excretion of uroporphyrin and heptacarboxyl porphyrin. Heterozygosity for mutations in the URO-D gene is found in the familial form of PCT (F-PCT). Over 70 mutations of URO-D have been described but very few have been characterized structurally. Here we characterize 3 mutations in the URO-D gene found in patients with F-PCT, G318R, K297N, and D306Y. Expression of the D306Y mutation results in an insoluble recombinant protein. G318R and K297N have little effect on the structure or activity of recombinant URO-D, but the proteins display reduced stability in vitro.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656450      PMCID: PMC2863003     

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  21 in total

1.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

2.  Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase.

Authors:  J D Phillips; T L Parker; H L Schubert; F G Whitby; C P Hill; J P Kushner
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

3.  Crystal structure of human uroporphyrinogen decarboxylase.

Authors:  F G Whitby; J D Phillips; J P Kushner; C P Hill
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

4.  Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda.

Authors:  Z J Bulaj; J D Phillips; R S Ajioka; M R Franklin; L M Griffen; D J Guinee; C Q Edwards; J P Kushner
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

5.  Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects.

Authors:  G H Elder; A G Roberts; R E de Salamanca
Journal:  Clin Biochem       Date:  1989-06       Impact factor: 3.281

6.  Characterization and crystallization of human uroporphyrinogen decarboxylase.

Authors:  J D Phillips; F G Whitby; J P Kushner; C P Hill
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

7.  Some kinetic properties of human red cell uroporphyrinogen decarboxylase.

Authors:  H de Verneuil; B Grandchamp; Y Nordmann
Journal:  Biochim Biophys Acta       Date:  1980-01-11

8.  Protein production by auto-induction in high density shaking cultures.

Authors:  F William Studier
Journal:  Protein Expr Purif       Date:  2005-05       Impact factor: 1.650

9.  Purification of uroporphyrinogen decarboxylase from human erythrocytes. Immunochemical evidence for a single protein with decarboxylase activity in human erythrocytes and liver.

Authors:  G H Elder; J A Tovey; D M Sheppard
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

10.  Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda.

Authors:  G H Elder; G B Lee; J A Tovey
Journal:  N Engl J Med       Date:  1978-08-10       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.